TrialAmerican journal of hematology2019

A prospective, multi-center, randomized comparison of iron isomaltoside 1000 versus iron sucrose in patients with iron deficiency anemia; the FERWON-IDA trial.

Michael Auerbach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.